ReviewDrug design, development and therapy2020

SGLT2 Inhibitors: A Novel Player in the Treatment and Prevention of Diabetic Cardiomyopathy.

Na Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.